XML 51 R21.htm IDEA: XBRL DOCUMENT v3.19.3

Financial Instruments	9 Months Ended
	Sep. 30, 2019
Investments All Other Investments [Abstract]
Financial Instruments	14. Financial Instruments Our financial instruments consist primarily of investments in cash and cash equivalents, receivables and certain other assets, foreign debt and accounts payable, which approximate fair value at September 30, 2019 and December 31, 2018, due to their short-term nature or variable, market-driven interest rates. The fair value of the debt issued under the Credit Facility was $69.4 million and $76.1 million at September 30, 2019 and December 31, 2018, respectively.  The fair value of the note payable was $1.7 million at December 31, 2018. At September 30, 2019 and December 31, 2018, the Company had cash and cash equivalents of $29.0 million and $43.7 million, respectively, of which $21.5 million and $23.3 million, respectively, was held outside of the United States, principally in the Netherlands, United Kingdom, China, and Canada.

X

- Definition

The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.

+ References

No definition available.

+ Details

Name:	us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration